Special Issue "Personalized Medicine in Blood Disease of Children"

Affiliations

¹ Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70010 Valenzano, Italy.
² Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.

Editorial

Adriana Ceci et al. J Pers Med. 2024.

. 2024 Mar 5;14(3):285.

doi: 10.3390/jpm14030285.

¹ Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70010 Valenzano, Italy.
² Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.

Abstract

Personalized medicine is defined as a medical model using the characterization of individuals' phenotypes and genotypes (e [...].

The authors declare no conflicts of interest.

1. European Commission Research and Innovation. [(accessed on 6 December 2023)]. Available online: https://research-and-innovation.ec.europa.eu/research-area/health/person....
1. Cappellini M.D., Marcon A., Fattizzo B., Motta I. Innovative Treatments for Rare Anemias. HemaSphere. 2021;5:e576. doi: 10.1097/HS9.0000000000000576. - DOI - PMC - PubMed
1. Adekile A., Akbulut-Jeradi N., Al Khaldi R., Fernandez M.J., Sukumaran J. Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing. J. Pers. Med. 2021;11:454. doi: 10.3390/jpm11060454. - DOI - PMC - PubMed
1. Akbulut-Jeradi N., Fernandez M.J., Al Khaldi R., Sukumaran J., Adekile A. Unique Polymorphisms at BCL11A, HBS1L-MYB and HBB Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease. J. Pers. Med. 2021;11:567. doi: 10.3390/jpm11060567. - DOI - PMC - PubMed
1. Meloni A., Pistoia L., Ricchi P., Putti M.C., Gamberini M.R., Cuccia L., Messina G., Massei F., Facchini E., Righi R., et al. Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia. J. Pers. Med. 2022;12:400. doi: 10.3390/jpm12030400. - DOI - PMC - PubMed